In addition, a shift in research emphasis from genomics to proteomics, the study of human proteins that are influenced by our genes, is expected to contribute to growth in both drug discovery and diagnostics. In a recent Time magazine special report, a panel of scientists and science writers was asked how genetics will change our lives in the next 50 years. A majority of the panelists pointed to the development of more personalized medicines, or so-called designer drugs – tailored to respond to individual needs. Pharmacogenomics, the study of how individual genetic variations affect the way we respond to drugs, is heavily dependent on lab testing. Fisher is well positioned to serve this emerging field by providing more technologically advanced diagnostics, a specialized life-science portfolio and pharmaceutical services to researchers. Customer Focus At a time when many companies are rediscovering the importance of the customer, we remind ourselves every day that serving the customer has been Fisher’s mission since the company was founded in 1902. But there is always room for improvement. To that end, we are investing in strengthening our sales, marketing and customer-service efforts worldwide, with particular emphasis on our chemical and reagent product lines and our pharmaceutical services business.

PAGE 4 OF 9